ESIC06 Aug 2026circularPrepared by Complied AI

Downward Rate Revision for Item No. 2128 under DGESIC RC-161

Official title

Downward Rate Revision for Item No. 2128 under DGESIC RC-161 of approved pharmaceutical firm M/s Johnson & Johnson Pvt. Ltd - reg

Official record

Open source page

AI-prepared change brief

Check the official record

What changed

The Employees' State Insurance Corporation has issued a downward rate revision for Item No. 2128 (Ibrutinib 140mg) under DGESIC Rate Contract 161, supplied by M/s. Johnson & Johnson Pvt. Ltd. The rate has been reduced from Rs. 1,557.39 per capsule to Rs. 1,448.69 per capsule, effective from April 8, 2026. Drawing and Disbursing Officers (DDOs) are required to recover the difference in rates for any supply orders placed on or after this date from subsequent bills submitted by the firm. The responsibility for reconciliation and recovery rests with the competent authorities and DDOs of the respective institutes.

Who is affected: M/s. Johnson & Johnson Pvt. Ltd
ESIC DDOs and Medical Institutes
Required action: Recover the difference in rates for supply orders placed on or after April 8, 2026, from subsequent bills.
Key dates: Effective date of rate revision — 07 Apr 2026
Thresholds: Revised rate of Rs. 1,448.69 per capsule.
Consequences: Recovery of excess payments from subsequent bills.

Prepared automatically from the captured official document and checked against source evidence. This is not an independent professional review. See how briefs are prepared. Verify material decisions against the official record.

Source details

Source: Employees' State Insurance Corporation
Type: circular
Published by source: 06 Aug 2026
Document number: U-25/12/159-164/Amend-Price/2025/Med.V (E:1222663)/211
Effective date: 07 Apr 2026
Coverage area: labour

Document text

Prepared for reading; wording retained from the source.

Verify official record

HEADQUARTERS EMPLOYEES' STATE INSURANCE CORPORATION (Ministry of Labour & Employment, Govt. of India) Panchdeep Bhawan, C.I.G. Marg, New Delhi-110002

U-25/12/159-164/Amend-Price/2025/Med.V (E:1222663)/211 Dt.: Signed Date

To, Director (Medical) Delhi/Director (Medical) NOIDA Dean, All ESIC PGIMSR's, Medical & Dental Colleges Medical Superintendents-All ESIC Hospitals Director, ESI Scheme-All States

Amendment - 17 /2026

Sub: Downward Rate Revision for Item No. 2128 under DGESIC RC-161 of approved pharmaceutical firm M/s Johnson & Johnson Pvt. Ltd - reg

Ref.: U-25/12/159to163/2022-Med.V(E-117064) wef 08.04.2025 to 07.04.2027

Sir/Madam,

The following amendment of Downward Rate Revision in r/o Item no. 2128 in RC161 of M/s. Johnson & Johnson Pvt. Ltd may please be noted:

RC No	Item No	Item Name and Description in DGESIC RC 161	Existing Rate	Amended/ Revised Rate wef. 08.04.2026	Recovery / Difference of rates (If any)
161	2128	Ibrutinib Tab/Cap- Each Cap/Tab to contain: Ibrutinib 140mg. Brand Name: Imbruvica ® Packing: Bottle of 90 Capsules GST @5% Extra	Rs.1,557.39 per Cap	Rs. 1,448.69 per Cap	Difference in rates to be deducted for supply orders placed wef 8th April 2026, if any

The said amendment has been issued on the request of the firm- M/s. Johnson & Johnson Pvt. Ltd

The drugs shall continue to adhere to composition, strength, standards and packing as approved under the respective DGESIC Rate Contract & conform to the standards and specifications as per the Drug & Cosmetic Act and/or any amendments thereof.
All DDOs are advised to recover the excess amount paid to the firm (i.e. difference in rates to be deducted for the Supply orders placed on/after 08.04.2026) from their subsequent bills submitted by the firms and maintain records of the same.
Reconciliation / recovery under the said amendment is the sole responsibility of the Competent Authority / DDOs of the respective institutes.

Digitally signed by Sanjiv Kochhar Date: 06-08-2026 11:18:25

(Sanjiv Kochhar) Director (Med.)

Copy for information to:

M/s. Johnson & Johnson Pvt. Ltd, 501-Arena Space, Behind Majas Depot, Jogeshwari, Mumbai-400060. (email: rasawale@its.jnj.com)
Website Content Manager with request for uploading on ESIC website.
Guard file / Spare copy

Research the source law

Find the provision behind this update.

No high-confidence provision match was found. Browse the law library, choose the affected provision and ask against the exact statutory text.

Browse source laws